Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12091405 Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors

Patent 12091405 was granted and assigned to Merck Sharp & Dohme Limited on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Merck Sharp & Dohme Limited

Current Assignee

Merck Sharp & Dohme Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120914050

Patent Inventor Names

Shuwen He0

Liangqin Guo0

Dane Clausen0

Theodore A. Martinot0

Guoqing Li0

Wensheng Yu0

Li Xiao0

Yongxin Han0

...

Date of Patent

September 17, 2024

Patent Application Number

172872560

Date Filed

October 28, 2019

Patent Citations

‌

US Patent 9540343 Compounds for the treatment of HIV

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12091405 Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API